United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Sep 17, 2026 · Filed Sep 18, 2026

On Sep 17, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$497.54 for US$4.13M under a trading plan, leaving 45,172 shares. Filed Sep 18, 2026 (Form 4).

Sold
8,300 shares
Price
US$497.54 average (US$495.97 to US$501.58)
Value
US$4.13M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 17, 2026Common StockOption exercise8,300US$146.0353,472Direct
Sep 17, 2026Common StockSale1,579US$495.9751,893Direct
Sep 17, 2026Common StockSale2,873US$496.5849,020Direct
Sep 17, 2026Common StockSale1,400US$497.5447,620Direct
Sep 17, 2026Common StockSale843US$498.7446,777Direct
Sep 17, 2026Common StockSale1,160US$499.7545,617Direct
Sep 17, 2026Common StockSale125US$500.8045,492Direct
Sep 17, 2026Common StockSale320US$501.5845,172Direct

Source

View original at SEC

Related